As of 2026-03-24, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -1.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 146.25 mil USD. EDIT's TTM EBITDA according to its financial statements is -96.25 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 11.2x | 8.7x |
| Forward P/E multiples | 7.9x - 15.7x | 11.8x |
| Fair Price | (6.99) - (10.10) | (9.18) |
| Upside | -391.1% - -520.9% | -482.5% |
| Date | EV/EBITDA |
| 2026-03-13 | -1.56 |
| 2026-03-12 | -1.66 |
| 2026-03-11 | -1.78 |
| 2026-03-10 | -1.76 |
| 2026-03-09 | -1.44 |
| 2026-03-06 | -1.11 |
| 2026-03-05 | -1.01 |
| 2026-03-04 | -1.31 |
| 2026-03-03 | -1.15 |
| 2026-03-02 | -1.27 |
| 2026-02-27 | -1.32 |
| 2026-02-26 | -1.30 |
| 2026-02-25 | -1.25 |
| 2026-02-24 | -1.23 |
| 2026-02-23 | -1.00 |
| 2026-02-20 | -0.90 |
| 2026-02-19 | -0.92 |
| 2026-02-18 | -0.83 |
| 2026-02-17 | -0.85 |
| 2026-02-13 | -0.87 |
| 2026-02-12 | -0.79 |
| 2026-02-11 | -0.88 |
| 2026-02-10 | -0.89 |
| 2026-02-09 | -0.92 |
| 2026-02-06 | -0.93 |
| 2026-02-05 | -0.77 |
| 2026-02-04 | -1.06 |
| 2026-02-03 | -1.17 |
| 2026-02-02 | -1.12 |
| 2026-01-30 | -1.10 |
| 2026-01-29 | -1.17 |
| 2026-01-28 | -1.17 |
| 2026-01-27 | -1.23 |
| 2026-01-26 | -1.17 |
| 2026-01-23 | -1.28 |
| 2026-01-22 | -1.50 |
| 2026-01-21 | -1.24 |
| 2026-01-20 | -1.13 |
| 2026-01-16 | -1.14 |
| 2026-01-15 | -1.21 |
| 2026-01-14 | -1.34 |
| 2026-01-13 | -1.21 |
| 2026-01-12 | -1.25 |
| 2026-01-09 | -1.18 |
| 2026-01-08 | -1.26 |
| 2026-01-07 | -1.28 |
| 2026-01-06 | -1.26 |
| 2026-01-05 | -1.10 |
| 2026-01-02 | -1.16 |
| 2025-12-31 | -1.16 |